Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

1(14.3%)

Phase 2

1(14.3%)

Phase 1

1(14.3%)

7Total

N/A(4)

Phase 3(1)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06318416Phase 1Recruiting

Precision Rifampin Trial for Personalized Dosing

Role: collaborator

NCT04172012Phase 3Completed

Use of Probiotics to Reduce Infections, Death and ESBL Colonisation

Role: lead

NCT03559582Completed

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Role: collaborator

NCT05121935Not Yet Recruiting

MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty

Role: collaborator

NCT03268902Phase 2Completed

Early Life Interventions for Childhood Growth and Development In Tanzania

Role: lead

NCT04565314Not ApplicableUnknown

ELICIT 2.0: Pilot Study of the Effect of Maternal Protein Supplementation During Lactation on Childhood Growth

Role: collaborator

NCT04404751Not ApplicableCompleted

Quadruple Fortified Salt Clinical Trial

Role: lead

NCT01869582Not ApplicableCompleted

Safer Births - Reducing Perinatal Mortality

Role: collaborator

NCT02971553Not ApplicableCompleted

PEEP Resuscitation Trial

Role: collaborator

All 9 trials loaded